Clinical Pathways Search Results

The penicillin drug allergy pathway is meant to guide providers in assessing whether patients with a reported or labeled penicillin drug allergy should avoid penicillin, remove the allergy label, or refer to an allergist for skin testing or oral drug challenge.

Inpatient and outpatient medical and surgical management for pediatric preseptal or orbital cellulitis patients

This pathway should be used to guide the evaluation and management of patients presenting with ultrasound findings of perinatal urinary tract dilation (UTD). This pathway should be used by pediatricians, neonatologists, and urologists to guide risk based evaluation and treatment based on pre-natal and post-natal ultrasound findings.

The Gastroenteritis Pathway is intended to guide inpatient evaluation and management of dehydration secondary to gastroenteritis in the pediatric patient.

The dental emergency pathway is meant to guide providers on the necessary steps in the evaluation and treatment of emergent dental pathology and/or trauma in the emergency department.

The Neurogenic bowel management clinical pathway in the pediatric patient with spina bifida ensures a consistent stepwise approach to social continence and independence throughout childhood and adolescence.

Clinical Pathway for Inpatient Recommendations for SARS-CoV-2 Testing provides guidance for the evaluation and care of patients with suspected coronavirus (SARS-CoV-2).

This pathway should be used to guide the evaluation and treatment of patients with fever and recent travel. ≥ 38 °C in a traveler within 30 days of return to the U.S.

This pathway guides the ED and inpatient care for patients of any age with Genetically confirmed, Primary (Definite) Mitochondrial Disease or Suspected Mitochondrial Disease.

This pathway guides clinicians in best practices for screening and treatment for adolescents presenting to the Emergency Department and Primary Care sites who might be at risk for sexually transmitted infections.